ID   Ltk-11
AC   CVCL_3738
DR   CLO; CLO_0007412
DR   CCRID; 1101MOU-PUMC000194
DR   Wikidata; Q54903178
RX   Patent=US6706716;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10422.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5289; HTR1D.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
RX   Patent=US6706716;
RA   Konkel, Michael J.
RA   Wetzel, John M.
RA   Noble, Stewart A.
RA   Gluchowski, Charles
RA   Craig, Douglas A.
RT   "Compounds specific for the human alpha1d adrenergic receptor and uses
RT   thereof.";
RL   Patent number US6706716, 16-Mar-2004.
//